Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors [Phase 1]
This is a Phase 1 dose-escalation trial of 2-Deoxy-D-glucose (2DG) in adults with advanced solid tumors, spanning multiple cancer types and …
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: ATAC - Bone Density Sub-Protocol [Phase 3]
Phase 3 ATAC trial's bone density sub-protocol has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study [Phase 2]
A Phase II neoadjuvant study in ER+/PgR+ breast cancer completed, evaluating Arimidex (anastrozole) with or without Iressa (gefitinib).
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Ph II Early BC Pre-Surgical Biologic Study [Phase 2]
Phase II study in breast cancer evaluating an early pre-surgical biologic approach has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of Iressa (gefitinib) and Faslodex (fulvestrant) in patients with advanced or metastatic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 study evaluating ZD1839 (Iressa) in combination with docetaxel as first-line therapy for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: IRESSA™ (Gefitinib) in Breast Cancer Patients [Phase 2]
This update reports on a Phase 2 trial of gefitinib (IRESSA) in breast cancer patients that has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: Quality Of Life While Receiving Faslodex
A completed clinical trial update reporting on quality of life for patients with breast cancer receiving Faslodex (fulvestrant).
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients
Observations from the regular use of Faslodex (fulvestrant) in patients with advanced breast cancer from a terminated clinical trial.
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: Second Line Breast Cancer Trial [Phase 3]
Phase 3 trial in second-line advanced breast cancer sponsored by AstraZeneca has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer [Phase 1]
Phase 1 study evaluating motexafin gadolinium in combination with docetaxel for advanced cancers; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: 131-I-TM-601 Study in Adults With Solid Tumors [Phase 1]
Phase 1 update on the radiopharmaceutical 131I-TM-601 in adults with solid tumors, including breast cancer, non-small cell lung cancer, mela…
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort. [Phase 3]
Phase 3 trial evaluating Acupression's bracelets for nausea and vomiting induced by FEC100 chemotherapy in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health [Phase 2]
Phase 2 clinical trial evaluating the effects of soy compounds on breast cancer, prostate cancer, and bone health. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating CpG 7909 in combination with trastuzumab (Herceptin) for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) [Phase 2]
Phase 2 clinical trial update on PF-3512676 (CPG 7909) for patients who completed an oncology study using the drug. The document notes that …
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg
This retrospective survey analyzes the incidence of bone fractures in patients treated with Arimidex (anastrozole) 1 mg for breast cancer.
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole
This clinical trial update reports on the assessment of endometrial changes in postmenopausal women with breast cancer receiving adjuvant tr…
-
CLINICAL_TRIALS trial_result · 2009-03-03Clinical Trial Update: Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers [Phase 1]
Phase 1 trial evaluating the safety and immunogenicity of CHP-HER2 and CHP-NY-ESO-1 protein vaccines with OK-432 in patients with antigen-ex…
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer [NA]
This clinical trial update reports a completed study examining bone mineral density in postmenopausal women after treatment for breast cance…
-
CLINICAL_TRIALS trial_result · 2009-02-25Clinical Trial Update: Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors [Phase 2]
A Phase 2 adjuvant breast cancer trial conducted by the Netherlands Working Party for Autotransplantation in Solid Tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer [Phase 3]
Phase 3 clinical trial comparing prolonged (extended-duration) tamoxifen therapy with shorter duration in patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer [NA]
This clinical trial update assesses adding darbepoetin alfa to combination chemotherapy for women with stage III breast cancer; the current …
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group [Phase 2, Phase 3]
Completed phase 2/3 trial of Removab (catumaxomab) in EpCAM-positive patients with symptomatic malignant ascites, comparing with an untreate…
-
CLINICAL_TRIALS trial_result · 2009-02-02Clinical Trial Update: Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 [EARLY_Phase 1]
Siemens Molecular Imaging completed an exploratory Phase 0 PET imaging study of the F-18 RGD-K5 tracer. The study evaluated imaging across m…